Results 241 to 250 of about 93,945 (299)

Total Neoadjuvant Therapy Versus Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: Real-World Tumor Response and Clinical Outcomes. [PDF]

Med Sci (Basel)
Lunca S, Ong WL, Morarasu S, Musina AM, Roata CE, Zaharia R, Dimofte GM.   +6 more
europepmc   +1 more source

Cisplatin-induced sarcoidosis-like reaction after primary chemoradiotherapy for locally advanced cervical cancer. [PDF]

BMJ Case Rep
Healsmith S, Foster L, Chard J, Brand A.
europepmc   +1 more source

Correction to "Macro Habitat-Based T2-Weighted MRI Radiomics and Deep Learning Fusion for Predicting Treatment Response and Prognosis After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer". [PDF]

Cancer Med
europepmc   +1 more source

Neoadjuvant chemoradiotherapy for esophageal carcinoma

Diseases of the Esophagus, 2005
SUMMARY. Neoadjuvant chemoradiotherapy is often administered to patients with esophageal carcinoma in the belief that this will improve survival. However, its role in the management of esophageal carcinoma remains controversial. In this study we evaluated our experience with neoadjuvant chemoradiotherapy for the treatment of esophageal carcinoma.
Zhang, X, Watson, David Ian, Jamieson, Glyn G, Bessell, Justin, Devitt, Peter G   +4 more
openaire   +4 more sources

Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer [PDF]

memo - Magazine of European Medical Oncology, 2020
In locally advanced rectal cancer, neoadjuvant chemoradiotherapy provides a significant benefit to local cancer control in addition to total mesorectal excision.
Fabian Lunger, Georgios Peros
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Chemoradiotherapy

Nihon Geka Gakkai zasshi, 2008
In Western countries, chemotherapy or chemoradiotherapy followed by surgery is the standard treatment and definitive chemoradiotherapy is also standard treatment option for localized advanced esophageal cancer. On the other hand, in Japan, only surgery is recognized as standard of care.
Marcel Verheij, Harry Bartelink
  +5 more sources

Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer

, 2020
In locally advanced rectal cancer, neoadjuvant chemoradiotherapy provides a significant benefit to local cancer control in addition to total mesorectal excision.
Lunger, Fabian, Peros, Georgios
openaire   +2 more sources

Chemoradiotherapy in gallbladder cancer

Journal of Surgical Oncology, 2006
AbstractGallbladder cancer (GC) is considered a rare disease associated with a poor prognosis. Unfortunately, the low number of cases makes the performance of trials addressing the role of adjuvant, neoadjuvant, and/or palliative therapy difficult. For a long time, the majority of trials were 5‐fluorouracil (5 FU)‐based, and results were uniformly poor.
Aretxabala, Xabier de, Roa, Juan Carlos, León, Jorge, Maluenda, Fernando, Roa, Iván, Berríos Flores, Marcela Paz, Hepp, Juan, Gallardo, Jorge, Córdova, Andrés   +8 more
openaire   +2 more sources

Concomitant chemoradiotherapy.

Journal of Clinical Oncology, 1990
The title of Table 4 in the review article "Concomitant Chemoradiotherapy: Rationale and Clinical Experience in Patients With Solid Tumors" by Vokes and Weichselbaum published in the May 1990 issue (J Clin Oncol 8:911–934, 1990) was incorrect. It should
Everett E. Vokes, Ralph R. Weichselbaum
openaire   +2 more sources

Chemoradiotherapy in Gastrointestinal Malignancies

Clinical Oncology, 2009
Over the past 30 years, significant advances have been made in the integration of radiation therapy and chemotherapy in the treatment of patients with localised gastrointestinal malignancies. The therapeutic goal of chemoradiotherapy is to enhance local control resulting in improved survival and outcome of these patients. To define the optimal sequence,
C G, Willett, B G, Czito
openaire   +2 more sources